Cutaneous Amyloidosis: A Pilot Study at a Teaching Hospital in New Delhi

Jairajpuri, Zeeba S; Rana, Safia; Khetrapal, Shaan; Arora, Pooja; Jetley, Sujata

doi:10.3329/jom.v19i1.34838

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The researchers found the average age of cases with amyloidosis between 28-48.35. [13,17,19,[23][24][25][26][27][28][29][30] In this study, the mean age of the patients with PCA was 49.3 years.…”

Section: Discussionmentioning

confidence: 72%

Clinical and Demographic Characteristics of The Patients with Diffuse Hyperpigmentation

Akbaş¹

2020

South Clin Ist Euras

View full text Add to dashboard Cite

Objective: Hyperpigmentation is a condition characterized by the accumulation of pigment in the epidermis and dermis. Many dermatological diseases, such as primary cutaneous amyloidosis (PCA), postinflammatory hyperpigmentation (PIH), erythema discromicum perstans (EDP), notalgia paresthetica (NP), drug reaction (DR), may lead to acquired hyperpigmentation on the skin. The aim of this study is to investigate etiologic factors, clinical and demographic features, laboratory findings and treatment options in patients with generalized hyperpigmentation.Methods: Forty four patients who presented to our outpatient clinic with complaints of hyperpigmentation were evaluated retrospectively. Patients were examined in terms of age, duration and localization of lesions, accompanying symptoms or diseases, laboratory findings and treatment options.Results: When pigmentation-causing diseases are listed; PCA was detected in 50% of the cases. Of these, 72.7% (n=16) were macular amyloidosis, 22.7% (n=5) were lichen amyloidosis, and 4.6% (n=1) were biphasic amyloidosis. Others were 29.5% (n=13) PIH, 13.6% (n=6) EDP, 4.6% (n=2) NP, 2.3% (n=1) DR. The ages of the patients were generally between 20-69 years. The average age was mean 47.8 years (48.8 for females and 45.0 for males). The duration of pigmentation ranged from 3 months to 20 years (mean 6.8 years). 75% (n=33) of the patients had itching. About half of the lesions were located on the back. Half of the patients had a concomitant disease. As treatment options, 9 patients were treated with phototherapy, 9 with isotretinoin, 12 with depigmentation, and one with pregabalin and topical steroids. Conclusion:Knowing the conditions that cause hyperpigmentation facilitates the diagnosis of the disease. In this study, PCA was detected in half of the patients with clinically considered hyperpigmentation. Therefore, the diagnosis of PCA should be considered first in patients with pruritic and diffuse pigmentation.

show abstract